Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells

被引:73
作者
Ames, Erik [1 ]
Canter, Robert J. [2 ]
Grossenbacher, Steven K. [1 ]
Mac, Stephanie [1 ]
Smith, Rachel C. [1 ]
Monjazeb, Arta M. [3 ]
Chen, Mingyi [4 ]
Murphy, William J. [1 ,5 ]
机构
[1] Univ Calif Davis, Davis Sch Med, Dept Dermatol, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Davis Sch Med, Dept Surg, Div Surg Oncol, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Davis Sch Med, Dept Radiat Oncol, Sacramento, CA 95817 USA
[4] Univ Calif Davis, Davis Sch Med, Dept Pathol, Sacramento, CA 95817 USA
[5] Univ Calif Davis, Davis Med Ctr, Dept Internal Med, Div Hematol & Oncol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
natural killer cells; adoptive immunotherapy; cancer stem cell; radiotherapy; BREAST-CANCER CELLS; INITIATING CELLS; IMMUNOTHERAPY; TRANSPLANTATION; IDENTIFICATION; CYTOTOXICITY; RESISTANCE; RECEPTORS; MARKERS; ALDH1;
D O I
10.1080/2162402X.2015.1036212
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Natural killer (NK) cells are innate lymphocytes postulated to mediate resistance against primary haematopoietic but not solid tumor malignancies. Cancer stem cells (CSCs) are a small subset of malignant cells with stem-like properties which are resistant to chemo-and radiotherapies and are able to repopulate a tumor after cytoreductive treatments. We observed increased frequencies of stem-like tumor cells after irradiation, with increased expression of stress ligands on surviving stem-like cells. Ex vivo NK cells activated by low dose IL2 in vitro and IL15 in vivo displayed an increased ability to target solid tumor stem-like cells both in vitro and in vivo after irradiation. Mechanistically, both upregulation of stress-related ligands on the stem-like cells as well as debulking of non-stem populations contributed to these effects as determined by data from cell lines, primary tumor samples, and most relevant patient derived specimens. In addition, pretreatment of tumor-bearing mice with local radiation prior to NK transfer resulted in significantly longer survival indicating that radiation therapy in conjunction with NK cell adoptive immunotherapy targeting stem-like cancer cells may offer a promising novel radio-immunotherapy approach in the clinic.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 35 条
[1]
Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]
Advantages and clinical applications of natural killer cells in cancer immunotherapy [J].
Ames, Erik ;
Murphy, William J. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (01) :21-28
[3]
High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition [J].
Awad, Ola ;
Yustein, Jason T. ;
Shah, Preeti ;
Gul, Naheed ;
Katuri, Varalakshmi ;
O'Neill, Alison ;
Kong, Yali ;
Brown, Milton L. ;
Toretsky, Jeffrey A. ;
Loeb, David M. .
PLOS ONE, 2010, 5 (11)
[4]
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[5]
Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation [J].
Barao, Isabel ;
Alvarez, Maite ;
Redelman, Doug ;
Weiss, Jonathan M. ;
Ortaldo, John R. ;
Wiltrout, Robert H. ;
Murphy, William J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (12) :1754-1764
[6]
Radiation and the microenvironment - Tumorigenesis and therapy [J].
Barcellos-Hoff, MH ;
Park, C ;
Wright, EG .
NATURE REVIEWS CANCER, 2005, 5 (11) :867-875
[7]
CD24-/low stem-like breast cancer marker defines the radiation-resistant cells involved in memorization and transmission of radiation-induced genomic instability [J].
Bensimon, J. ;
Altmeyer-Morel, S. ;
Benjelloun, H. ;
Chevillard, S. ;
Lebeau, J. .
ONCOGENE, 2013, 32 (02) :251-258
[8]
Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump [J].
Burger, H ;
van Tol, H ;
Boersma, AWM ;
Brok, M ;
Wiemer, EAC ;
Stoler, G ;
Nooter, K .
BLOOD, 2004, 104 (09) :2940-2942
[9]
Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma [J].
Canter, Robert J. ;
Ames, Erik ;
Mac, Stephanie ;
Grossenbacher, Steven K. ;
Chen, Mingyi ;
Li, Chin-Shang ;
Borys, Dariusz ;
Smith, Rachel C. ;
Tellez, Joe ;
Sayers, Thomas J. ;
Monjazeb, Arta M. ;
Murphy, William J. .
BMC CANCER, 2014, 14
[10]
NK cell-based immunotherapy for malignant diseases [J].
Cheng, Min ;
Chen, Yongyan ;
Xiao, Weihua ;
Sun, Rui ;
Tian, Zhigang .
CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (03) :230-252